Medicine

Lessons from an unfavorable genetics therapy test for Duchenne muscle dystrophy

.Attributes Medicine, Published online: 09 October 2024 doi:10.1038/ s41591-024-03316-9Delandistrogene moxeparvovec obtained FDA approval after a negative test, which highlights the numerous complexities as well as obstacles of medicine advancement within this environment.

Articles You Can Be Interested In